Fleming, T., Borer, J., Armstrong, P. W., Pfeffer, M., & Food and Drug Administration. Cardiovascular and Renal Drugs Advisory Committee. (2003). Food and Drug Administration: Cardiovascular and Renal Drugs Advisory Committee, 98th meeting, January 6th-7th, 2003. Circulation, 107(2), e9002–e9003. https://doi.org/10.1161/01.cir.0000057552.70961.f3

Fleming, Thomas, Jeff Borer, Paul W. Armstrong, Marc Pfeffer, and Food and Drug Administration. Cardiovascular and Renal Drugs Advisory Committee. “Food and Drug Administration: Cardiovascular and Renal Drugs Advisory Committee, 98th meeting, January 6th-7th, 2003.” Circulation 107, no. 2 (January 21, 2003): e9002–3. https://doi.org/10.1161/01.cir.0000057552.70961.f3.

Fleming T, Borer J, Armstrong PW, Pfeffer M, Food and Drug Administration. Cardiovascular and Renal Drugs Advisory Committee. Food and Drug Administration: Cardiovascular and Renal Drugs Advisory Committee, 98th meeting, January 6th-7th, 2003. Circulation. 2003 Jan 21;107(2):e9002–3.

Fleming, Thomas, et al. “Food and Drug Administration: Cardiovascular and Renal Drugs Advisory Committee, 98th meeting, January 6th-7th, 2003.” Circulation, vol. 107, no. 2, Jan. 2003, pp. e9002–03. Pubmed, doi:10.1161/01.cir.0000057552.70961.f3.

Fleming T, Borer J, Armstrong PW, Pfeffer M, Food and Drug Administration. Cardiovascular and Renal Drugs Advisory Committee. Food and Drug Administration: Cardiovascular and Renal Drugs Advisory Committee, 98th meeting, January 6th-7th, 2003. Circulation. 2003 Jan 21;107(2):e9002–e9003.